David M. Goldstein

Director Técnico/Científico/I+D en PRINCIPIA BIOPHARMA INC. .

58 años

Health Technology

Consumer Services

Relaciones activas

Nombre	Sexo	Edad	Empresas relacionadas	Colaboración
Severin Schwan	M	57	ROCHE HOLDING AG	16 años
Chris Varma	M	-	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	6 años
André S. Hoffmann	M	66	ROCHE HOLDING AG	28 años
Othman Laraki	M	46	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	-
Betsy Santos	F	-	PRINCIPIA BIOPHARMA INC.	-
Daniel K. Nomura	M	-	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	6 años
Roberto Zoncu	M	-	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	6 años
Thomas Schinecker	M	49	ROCHE HOLDING AG	21 años
Luke Evnin	M	60	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	-
John Reed	M	65	PRINCIPIA BIOPHARMA INC.	-
Paul Laland	M	-	PRINCIPIA BIOPHARMA INC.	-
Pamela Klein	M	63	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	1 años
Janwillem Naesens	M	41	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	-
Cameron Wheeler	M	45	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	-
Setareh Pouraghabagher	F	53	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	2 años
Joan S Brugge	M	-	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	-

Gráfico relacional

Relaciones con varias empresas

Antiguas relaciones

Nombre	Sexo	Edad	Empresas relacionadas	Colaboración
DeAnne Shirley Julius	M	75	ROCHE HOLDING AG	14 años
Erich Hunziker	M	70	ROCHE HOLDING AG	10 años
Andreas Oeri	M	75	ROCHE HOLDING AG	24 años
Walter Frey	M	80	ROCHE HOLDING AG	10 años
John Bell	M	71	ROCHE HOLDING AG	19 años
Lodewijk J. R. de Vink	M	78	ROCHE HOLDING AG	9 años
Christopher Chai	M	58	PRINCIPIA BIOPHARMA INC.	7 años
Martin Babler	M	59	PRINCIPIA BIOPHARMA INC.	9 años
Peter Thompson	M	64	PRINCIPIA BIOPHARMA INC.	8 años
Paul Bulcke	M	69	ROCHE HOLDING AG	11 años
Horst Teltschik	M	83	ROCHE HOLDING AG	-
Simeon George	M	46	PRINCIPIA BIOPHARMA INC.	9 años
Wolfgang Ruttenstorfer	M	73	ROCHE HOLDING AG	4 años
Christoph Franz	M	64	ROCHE HOLDING AG	12 años
Roy C. Hardiman	M	64	PRINCIPIA BIOPHARMA INC.	5 años
Pius Baschera	M	73	ROCHE HOLDING AG	10 años
Bruno Gehrig	M	77	ROCHE HOLDING AG	9 años
Domenico Scala	M	59	ROCHE HOLDING AG	8 años
John Smither	M	71	PRINCIPIA BIOPHARMA INC.	-
Henri-Paul Meier	M	-	ROCHE HOLDING AG	-
Dan Becker	M	49	PRINCIPIA BIOPHARMA INC.	3 años
Clive Meanwell	M	67	ROCHE HOLDING AG	9 años
Arthur Levinson	M	73	ROCHE HOLDING AG	-
Alan Colowick	M	61	PRINCIPIA BIOPHARMA INC.	3 años
William Burns	M	76	ROCHE HOLDING AG	4 años
Beatrice Weder di Mauro	M	57	ROCHE HOLDING AG	10 años
Vincent Charlon	M	-	ROCHE HOLDING AG	8 años
Steve Krognes	M	56	ROCHE HOLDING AG	5 años
Jean-Jacques Garaud	M	68	ROCHE HOLDING AG	5 años
Klaus Gustav Strein	M	-	ROCHE HOLDING AG	13 años
Unni Hjelmaas	F	-	ROCHE HOLDING AG	3 años
Michael Burgess	M	61	ROCHE HOLDING AG	-
David Kabakoff	M	76	PRINCIPIA BIOPHARMA INC.	2 años
Torsten Hoffmann	M	57	ROCHE HOLDING AG	16 años
Greg S. Yap	M	-	ROCHE HOLDING AG	3 años
Shawn Tomasello	F	65	PRINCIPIA BIOPHARMA INC.	1 años
Michael Mulqueen	M	-	ROCHE HOLDING AG	13 años
Michael Byrnes	M	47	PRINCIPIA BIOPHARMA INC.	-
Olivia Ware	F	67	PRINCIPIA BIOPHARMA INC.	2 años
Luca Santarelli	M	55	ROCHE HOLDING AG	8 años
Shao Lee Lin	M	57	PRINCIPIA BIOPHARMA INC.	1 años
Christopher Vann	M	59	ROCHE HOLDING AG	22 años
Stefani Wolff	F	62	PRINCIPIA BIOPHARMA INC.	4 años
Dolca Thomas	M	53	PRINCIPIA BIOPHARMA INC.	2 años
Marc M. Gibeley	M	59	ROCHE HOLDING AG	5 años
Anton Affentranger	M	68	ROCHE HOLDING AG	-
Dirk W. Kirsten	M	56	ROCHE HOLDING AG	2 años
Bradley Bolzon	M	64	ROCHE HOLDING AG	4 años
Peter Brabeck-Letmathe	M	79	ROCHE HOLDING AG	10 años
Clarence Machado	M	60	PRINCIPIA BIOPHARMA INC.	1 años
Lewis J. Shuster	M	68	PRINCIPIA BIOPHARMA INC.	-
Stephen Hill	M	65	ROCHE HOLDING AG	2 años
Hany Massarany	M	62	ROCHE HOLDING AG	2 años
Franz Humer	M	76	ROCHE HOLDING AG	19 años
Richard Scheller	M	70	ROCHE HOLDING AG	5 años
Rolf Hänggi	M	81	ROCHE HOLDING AG	10 años
Per-Olof Attinger	M	64	ROCHE HOLDING AG	-
Eduard Enrico Holdener	M	79	ROCHE HOLDING AG	12 años
Rolf Schläpfer	M	68	ROCHE HOLDING AG	-
Gerald Heinz Möller	M	80	ROCHE HOLDING AG	-
Phyllis Whiteley	M	-	ROCHE HOLDING AG	5 años
Jürg Witmer	M	75	ROCHE HOLDING AG	21 años
Myriam Meyer Stutz	M	62	ROCHE HOLDING AG	3 años
Steven G. Gourlay	M	64	PRINCIPIA BIOPHARMA INC.	5 años
Michael Dybbs	M	49	PRINCIPIA BIOPHARMA INC.	2 años
Mohammad Masjedizadeh	M	-	PRINCIPIA BIOPHARMA INC.	5 años

Estadísticas

País	Relaciones	% del total
Suiza	49	59.76%
Estados Unidos	33	40.24%

Antigüedad de la relación

Activas

Pasados

Hombre

Mujer

Administradores

Ejecutivos

Origen de las relaciones